首页> 外文期刊>Experimental Gerontology >T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8~+CD28~+ T cells but not in CD8~+CD28~- T cells
【24h】

T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8~+CD28~+ T cells but not in CD8~+CD28~- T cells

机译:T细胞受体介导的活化是人CD8〜+ CD28〜+ T细胞中的显微染球的有效诱导剂,但不含CD8〜+ CD28〜-T细胞

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A key feature of the aged human immune system is the accumulation of highly differentiated CD8~+CD28~ T cells, a phenomenon that negatively influences immune function in the elderly. However, the mechanisms that regulate survival or death of CD8~+CD28~- T cells remain incompletely understood. Macroautophagy has been shown to protect cells from unfavorable environmental conditions and extend lifespan of various cells and organisms. In this study, we investigated autophagy in CD8~+CD28~+ and CD8~+CD28~ -T cells following T cell receptor (TCR) engagement. We demonstrate that TCR-mediated activation led to a potent induction of autophagy in CD8~+CD28~+ T cells which was accompanied by an increased activity of the mammalian target of rapamycin complex 1 (mTORCl). This was surprising, as mTORCl is generally perceived as an inhibitor of autophagy. Inhibition of mTORCl by rapamycin could still enhance activation-induced autophagy. In contrast, CD8~+CD28~- T cells induced autophagy to a significantly lower extent in response to TCR engagement compared to CD8~+CD28~+ T cells and failed to increase autophagy upon mTORCl inhibition. In conclusion, we describe for the first time the induction of autophagy in human CD8~+ T cells following TCR engagement and the decreased ability of CD8~+CD28~ T cells to induce autophagy, suggesting that they cannot meet the metabolic needs of antigen receptor-mediated activation and are therefore unlikely to survive when confronted by their specific antigens.
机译:老年人免疫系统的关键特征是高分辨率的CD8〜+ CD28〜T细胞的积累,这是一种对老年人免受免疫功能的现象。然而,调节CD8〜+ CD28〜 - T细胞存活或死亡的机制仍然不完全理解。已显示宏观摄影以保护细胞免受不利的环境条件,并延长各种细胞和生物的寿命。在这项研究中,在T细胞受体(TCR)接合后,我们研究了CD8〜+ CD28 +和CD8〜+ CD28〜-T细胞的自噬。我们证明TCR介导的活化导致CD8〜+ CD28〜+ T细胞中自噬诱导,其伴随着哺乳动物络合物1(MTORCL)的哺乳动物靶标的活性增加。这令人惊讶,因为MTORCL通常被认为是自噬抑制剂。通过雷帕霉素抑制MTORCL仍可增强活化诱导的自噬。相比之下,与CD8〜+ CD28 + T细胞相比,CD8〜+ CD28〜-T细胞响应TCR接合而致急性降低的程度,并且在MTORCL抑制时未能增加自噬。总之,我们首次描述了TCR接合后人CD8〜+ T细胞中自噬诱导和CD8〜+ CD28〜T细胞诱导自噬的能力降低,表明它们不能满足抗原受体的代谢需求导介的活化,因此在由其特异性抗原面对时不太可能存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号